Ra Medical Systems, Inc. (RMED)

NYSEAMERICAN: RMED · IEX Real-Time Price · USD
1.06 -0.10 (-8.62%)
Jan 21, 2022 4:00 PM EST - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019201820172016
Net Income
-36.05-56.96-30.83-17.77-4.2
Depreciation & Amortization
2.371.750.620.220.1
Share-Based Compensation
4.0823.5414.7312.712.3
Other Operating Activities
1.29-1.51-3.03-0.68-0.08
Operating Cash Flow
-28.3-33.17-18.51-5.52-1.89
Capital Expenditures
-0.07-0.27-0.58-0.55-0.21
Change in Investments
16-15.76000
Investing Cash Flow
15.93-16.03-0.58-0.55-0.21
Share Issuance / Repurchase
19.990.0475.2510.435.27
Debt Issued / Paid
1.71-0.34-0.08-0.040.11
Other Financing Activities
0-0.23000
Financing Cash Flow
21.69-0.5375.1710.395.37
Net Cash Flow
9.32-49.7356.084.323.28
Free Cash Flow
-28.37-33.44-19.09-6.07-2.1
Free Cash Flow Margin
-644.06%-464.52%-305.10%-103.41%-35.07%
Free Cash Flow Per Share
-16.70-63.58-51.71-20.11-7.54
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).